Please assess the completion status of the following clinical trial:

Trial Title: A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients \>=18 years of age~* Locally advanced or metastatic colorectal cancer~* No previous treatment with chemotherapy for metastatic disease~* Measurable and/or evaluable lesions~Exclusion Criteria:~* Radiotherapy within 4 weeks before study~* Untreated brain metastases or primary brain tumors~* Chronic, daily treatment with high-dose aspirin (\>325mg/day)~* Co-existing malignancies, or malignancies diagnosed within the last 5 years, with the exception of basal and squamous cell cancer, or cervical cancer in situ

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).